Chelsea Therapeutics International Reaches New 12-Month High at $5.78 (CHTP)
Chelsea Therapeutics International (NASDAQ:CHTP)’s share price reached a new 52-week high on Wednesday, Analyst Ratings Net reports. The company traded as high as $5.78 and last traded at $4.45, with a volume of 43,969,473 shares traded. The stock had previously closed at $2.30.
A number of research firms have recently commented on CHTP. Analysts at Deutsche Bank raised their price target on shares of Chelsea Therapeutics International from $4.00 to $5.00 in a research note to investors on Wednesday. They now have a “hold” rating on the stock. Separately, analysts at Ladenburg Thalmann raised their price target on shares of Chelsea Therapeutics International to $7.00 in a research note to investors on Wednesday. Finally, analysts at Needham & Company raised their price target on shares of Chelsea Therapeutics International from $4.00 to $8.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $7.00.
Chelsea Therapeutics International has a one year low of $0.76 and a one year high of $4.53. The stock has a 50-day moving average of $3.73 and a 200-day moving average of $3.12. The company’s market cap is $316.3 million.
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.